Trial Profile
A Randomized, Open-label, Crossover Study to Assess the Safety, Tolerability, and Pharmacodynamics of PUL-042 Inhalation Solution in Healthy Subjects and the Effect of Pretreatment With Cromolyn Sodium or Albuterol Sulfate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs ODN/Pam2 (Primary)
- Indications Pneumocystis pneumonia
- Focus Adverse reactions
- Sponsors Pulmotect
- 29 Sep 2016 Status changed from recruiting to completed.
- 06 Oct 2015 New trial record